|Home||Internet of Things||Aerospace||Apparel||Energy||Defense||Health Care||Logistics||Manufacturing||Retail|
Merger Creates RFID-heavy Mailorder Pharmacy
A new mail-order prescription company named NEXT GENeSYS was formed this week through a four-way merger. The company plans to use RFID heavily in its delivery infrastucture.
Aug 25, 2004—This article was originally published by RFID Update.
August 25, 2004—A new company named NEXT GENeSYS was formed this week by the four-way merger between FutureCom Global, CareDecision, CareGeneration, and KCWG Pharmaceutical Solutions. The new company, which will make heavy use of RFID to sell prescription drugs by mail to uninsured individuals, has a predicted market capitalization of $65 million. The company hopes to leverage RFID and other wireless applications to succeed where others failed in providing pharmaceuticals by mail.
Read the article at eWeek
Login and post your comment!
Not a member?
Signup for an account now to access all of the features of RFIDJournal.com!
SEND IT YOUR WAY
RFID JOURNAL EVENTS
ASK THE EXPERTS
Simply enter a question for our experts.
TAKE THE POLL
|RFID Journal LIVE!||RFID in Health Care||LIVE! LatAm||LIVE! Brasil||LIVE! Europe||RFID Connect||Virtual Events||RFID Journal Awards||Webinars||Presentations|